Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Dec 7;14(12):e32298.
doi: 10.7759/cureus.32298. eCollection 2022 Dec.

Withdrawal of Gamma-Hydroxybutyrate in a Saudi Male Patient: A Case Report

Affiliations
Case Reports

Withdrawal of Gamma-Hydroxybutyrate in a Saudi Male Patient: A Case Report

Ibtihal M Alattas et al. Cureus. .

Abstract

Gamma-hydroxybutyrate (GHB) is a central nervous system (CNS) depressant with limited clinical use but has been misused in the last few decades. During intoxication, the patient may develop CNS depression and may have agitation, while during withdrawal, the patient can present with severe agitation or delirium. Here, we report the case of a 30-year-old Saudi male patient who was brought by his brother to the emergency department (ED) with agitation and delirium. The patient's friend stated the patient had been misusing GHB mixed with alcohol for the last seven months, with the last use occurring 24 hours before the ED presentation. The patient was put on a five-point restraint for safety concerns and received supportive therapy. After two days of admission, the patient completely recovered. As the patient provided a limited history of his GHB misuse, the clinician lacked sufficient information to determine whether the patient was intoxicated or withdrawing. Clinicians in Saudi Arabia need to be highly suspicious of GHB misuse when treating patients with drug intoxication or withdrawal.

Keywords: cns depressant; date rape drug; gamma-hydroxybutyrate; ghb; ghb intoxication; ghb withdrawal.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Similar articles

References

    1. γ-Hydroxybutyric acid: pharmacokinetics, pharmacodynamics, and toxicology. Felmlee MA, Morse BL, Morris ME. AAPS J. 2021;23:22. - PMC - PubMed
    1. Gamma-hydroxybutyric acid. Snead OC 3rd, Gibson KM. N Engl J Med. 2005;352:2721–2732. - PubMed
    1. Haroz R, Farmer BM. Goldfrank’s Toxicologic Emergencies, 11e. New York: McGraw Hill; 2019. γ-Hydroxybutyric acid (γ-hydroxybutyrate)
    1. Gamma-hydroxybutyrate detoxification by titration and tapering. de Jong CA, Kamal R, Dijkstra BA, de Haan HA. Eur Addict Res. 2012;18:40–45. - PubMed
    1. GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome. Busardò FP, Jones AW. Curr Neuropharmacol. 2015;13:47–70. - PMC - PubMed

Publication types

LinkOut - more resources